1. Long-term survival in a patient with low-level inflammatory markers and liver metastasis, converted resectable by TACE
   Malkhaz Mizandari et al, 2017, Immunotherapy CrossRef
2. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
   Jian Hu et al, 2018, BMC Gastroenterology CrossRef
3. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease
   Ayman Alsebaey et al, 2018, European Journal of Gastroenterology & Hepatology CrossRef
4. Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases
   Sean M. McDermott et al, 2018, Journal of Surgical Research CrossRef
5. Mean corpuscular hemoglobin concentration correlates with prognosis of resected hepatocellular carcinoma
   Weihao Kong et al, 2020, Biomarkers in Medicine CrossRef
6. A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma
   Jun Fu et al, 2023, BMC Cancer CrossRef
7. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE
   Yuxin Liang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
8. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy
   Younghee Park et al, 2022, The Korean Journal of Gastroenterology CrossRef
9. Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis
   Shuangshuang Li et al, 2020, PLOS ONE CrossRef
10. Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
    Liang Xiao et al, 2019, Bioscience Reports CrossRef
11. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma
    Peng Li et al, 2018, Bioscience Reports CrossRef
12. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
    Young Chang et al, 2020, International Journal of Molecular Sciences CrossRef
13. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma
    Baojiang Liu et al, 2019, Journal of Interventional Medicine CrossRef
14. Comparison of radiologic response criteria as predictors for refractoriness and survival to transarterial chemoembolization among hepatocellular cancer: Outcomes from a Southeast Asian cohort
    Rudolf V. Kuhn et al, 2022, American Journal of Interventional Radiology CrossRef
15. Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis
    Shuai Wang et al, 2024, Heliyon CrossRef
16. Prognostic significance of peripheral blood‐derived neutrophil/lymphocyte ratio in patients with digestive cancer
    Fangteng Liu et al, 2019, Journal of Cellular Physiology CrossRef
17. Predictors of Refractoriness and Survival following Transarterial Chemoembolization for Hepatocellular Carcinoma: Outcomes from a Southeast Asian Cohort
    Rudolf V. Kuhn et al, 2023, Journal of Clinical Interventional Radiology ISVIR CrossRef
18. Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysis
    Hong-Lin Chen et al, 2021, Arab Journal of Gastroenterology CrossRef
19. The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
    Mengyuan Li et al, 2023, Frontiers in Immunology CrossRef
20. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization
    Chang Liu et al, 2017, Medicine CrossRef
21. Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort
    Shamar Young et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
22. Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization
    Chang Liu et al, 2017, Scientific Reports CrossRef
23. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection
    Chuan Li et al, 2018, Medicine CrossRef
24. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization
    H Elalfy et al, 2018, British Journal of Biomedical Science CrossRef